Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. - Wikidata - awgldk - TriplyDB

Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes.

Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes.

http://www.wikidata.org/entity/Q34437623

about

Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum.Clinical, epidemiological, and therapeutic profile of dermatophytosis.Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum Comparison of the in vitro activities of newer triazoles and established antifungal agents against Trichophyton rubrum In vitro activities of miltefosine and two novel antifungal biscationic salts against a panel of 77 dermatophytes.Critical review on retrospective and prospective changes in antifungal susceptibility testing for dermatophytes.Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran.In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method.Comparison of in vitro activity of five antifungal agents against dermatophytes, using the agar dilution and broth microdilution methods.Isolation, Identification, and In Vitro Antifungal Susceptibility Testing of Dermatophytes from Clinical Samples at Sohag University Hospital in Egypt In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes.Antifungal susceptibility and virulence factors of clinically isolated dermatophytes in Tehran, Iran.The anti-dermatophyte activity of Commiphora molmol.Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes.Sequenced dermatophyte strains: growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model Effect of culture medium on the disk diffusion method for determining antifungal susceptibilities of dermatophytes.Evaluation of disk diffusion method for determining eberconazole susceptibility of dermatophytes and influence of culture medium Synthesis, structure, and antifungal evaluation of some novel 1,2,4-triazolylmercaptoacetylthiosemicarbazide and 1,2,4-triazolylmercaptomethyl-1,3,4-thiadiazole analogs.Global transcriptional profiles of Trichophyton rubrum in response to Flucytosine.In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.In vitro susceptibility of dermatophytes isolated from patients with end-stage renal disease: a case-control study.Preanalytical conditions for broth microdilution antifungal susceptibility of Microsporum spp.In vitro antifungal activity of sertaconazole against 309 dermatophyte clinical isolates.In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.Chemical composition and antimicrobial activity of the volatile fractions from leaves and flowers of the wild Iraqi Kurdish plant Prangos peucedanifolia FENZL.Antifungal susceptibility and genotypical pattern of Microsporum canis strains.Dermatophyte susceptibilities to antifungal azole agents tested in vitro by broth macro and microdilution methods.Antifungal activity of essential oils of Croton species from the Brazilian Caatinga biome.In vitro susceptibility testing of dermatophytes isolated from pediatric cases in Nigeria against five antifungals.Antifungal activities of different extracts of marine macroalgae against dermatophytes and Candida species.Antifungal susceptibility of dermatophytes isolated from patients with chronic renal failure.Dermatophyte susceptibility varies towards antimicrobial textiles.Synthesis, characterization, and antimicrobial evaluation of some new hydrazinecarbothioamide, 1,2,4-triazole and 1,3,4-thiadiazole derivatives.Therapy and Antifungal Susceptibility Profile of HPLC quantitative analysis of rhein and antidermatophytic activity of Cassia fistula pod pulp extracts of various storage conditions

P2860

Q26750760-9DB64F8B-8A44-463D-A9E3-5C9B873CED76 Q33261315-912E5862-7D1C-47BE-BA84-D534711A6E72 Q33558554-A318AA2F-E3BB-4CAD-BA86-5938878E0678 Q33753320-1B39FB5B-A880-4626-BDA1-4B95885B8BFB Q35746245-5DF8975B-2284-4FAD-AC6B-0980748F7D18 Q35840802-9933DDAB-F582-4117-8525-612670096A2D Q38862785-E5EEB4F2-F404-45F8-B270-6649DF759C71 Q38876515-9D64AA23-98F8-4287-BB54-6C72A10B0098 Q38878593-FA942616-D8AE-472A-8CBC-B9365494E8E2 Q39274300-19777594-FE04-4D42-AE7A-B33E377B8B9A Q39509156-9A20777D-8943-4F81-BC23-04756653D5C5 Q40173073-B01806DE-15F9-4C56-8EAF-01EBD4CE60F7 Q40245064-D024DAC2-EABC-4705-B23D-6AD1A28726F5 Q40970485-0F7E4367-C8C7-4305-B2B0-20AA8B681835 Q41869129-EF2B09D7-9D95-4836-A75A-73275E9E76CC Q42018772-54C34550-F76C-4F1D-BA25-9B79E9A0F9E9 Q42408761-A3FE372C-B2F1-4E93-AB70-3CE5C3E3CC7F Q42727529-37F6D029-BAFF-44ED-93DC-3E03FAAA7295 Q43210234-CC2CBBE6-3FB9-495F-AE57-091F3CAA4E60 Q43217794-E7B85962-C50F-48F2-ABEE-AA0B20A7E61A Q43532827-C9AF55A2-AB8D-450E-ABCB-246555CE38FB Q43753731-41329A5A-948B-4DD2-BC9D-67B91C291C47 Q44657018-E19699E8-EFBE-4FB9-9E25-BB44D52CA0E0 Q44784719-9D4B9DEB-C6ED-4B93-95CB-8485DE081363 Q45002264-5E3621A5-A090-4D0B-B548-14470D849175 Q45193865-0427F553-3FC7-4FBF-BC62-C6AB1964DAF8 Q46034293-DE89ED82-4563-4ECD-AE97-18F8733F3305 Q46668217-182B8235-1FD4-4C21-80D1-2E280AD4F88D Q46713207-EF662AB8-731E-4700-B0E8-A661EB54BB5B Q46734912-EED65690-398D-4518-8C00-257C83385CAE Q46890845-C068785D-45BE-4E93-B619-5DC6CC2B2941 Q50498536-59C301A5-06DD-4482-944D-30624F6F71A9 Q51001702-1541D96E-5A55-421C-95EF-3523B273AAC9 Q52616253-6F9D0566-3F9C-48AE-819A-E43DD5FA3794 Q54331273-CD8E0EB1-BAB5-459C-A950-821F7FC9F054 Q58762553-C49F6FF4-1005-4E06-8A4F-A726CA414032 Q58920658-670C3A15-71CB-4C16-B625-361CB1B99884

P2860

Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes.

http://www.wikidata.org/entity/Q34437623

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Collaborative evaluation of op ...... conditions for dermatophytes.

@ast

Collaborative evaluation of op ...... conditions for dermatophytes.

@en

Collaborative evaluation of op ...... conditions for dermatophytes.

@nl

type

label

Collaborative evaluation of op ...... conditions for dermatophytes.

@ast

Collaborative evaluation of op ...... conditions for dermatophytes.

@en

Collaborative evaluation of op ...... conditions for dermatophytes.

@nl

prefLabel

Collaborative evaluation of op ...... conditions for dermatophytes.

@ast

Collaborative evaluation of op ...... conditions for dermatophytes.

@en

Collaborative evaluation of op ...... conditions for dermatophytes.

@nl

P1433

Q34437623-D08C56C7-3D34-4FDD-B9E9-46F31796875C

P1476

Q34437623-A7D7783E-EC0C-4764-A7D9-32FE2E3E9A77

P2093

Q34437623-62BEAFD6-D849-4D4F-90DC-1DB9DA201ABF

Q34437623-AE99BCEF-9A68-49A7-90DB-382D6688DE22

Q34437623-CE53CD53-EA81-4DB4-BF67-B5485C679FB5

P2860

Q34437623-01EDFE42-4FF5-4BEC-9B7E-A8D817BB3F73

Q34437623-149EF131-5284-4880-8667-E42C5E0B0F4A

Q34437623-3198189B-3F5C-4527-A786-F903831C4F4A

Q34437623-477281BE-B747-47F1-BD81-05BFA0E9EAC9

Q34437623-4F84F75A-5B14-43AF-9B55-E6B2B36A7F1E

Q34437623-52038D22-647E-481C-AA8E-4CF85236F575

Q34437623-675DA6FE-DC81-4F5C-85C2-3BE71E0A6108

Q34437623-680E06C1-5799-4189-8026-803F1DF043AB

Q34437623-6855EB55-ED3A-4316-9F12-A1BBD2D319CF

Q34437623-6E62B1A0-27DD-40A9-8AB9-59836516D2F8

P304

Q34437623-54BEBDF2-0AE5-4436-B240-484B3BAEE55E

P31

Q34437623-CD38BD36-1F19-4851-98A1-605668386A44

P356

Q34437623-EA51E29A-133E-4AEF-BC40-BD8D94B8DE97

P407

Q34437623-63CEABDE-CFA8-4CB3-BCA0-A6D1579E27A7

P433

Q34437623-795FC38E-717C-4277-8DE3-63D44C944E1F

P478

Q34437623-BFB75BD8-2955-4F95-83D5-C2F3E861E7AC

P50

Q34437623-1679E30C-F761-4913-98D7-2318D63B54BD

Q34437623-3CAC7FA5-E960-408B-9F01-622271A4B762

Q34437623-B50D1383-E800-4792-B938-653F50A20A7E

Q34437623-F03133A3-54CC-4F5A-88FA-1D4FBC9BE86D

P577

Q34437623-3F8D447D-81FE-4531-ACF4-099BC61F8628

P698

Q34437623-96AB3C4A-DF90-4642-A756-403B9F9E0EFF

P921

Q34437623-B07FE662-A2C3-4990-8858-FFF5F7D5E60D

P932

Q34437623-4C45AF70-C8CC-4C25-AB1A-2988EA191B99

P356

JCM.40.11.3999-4003.2002

P1433

Journal of Clinical Microbiology

P1476

Collaborative evaluation of op ...... g conditions for dermatophytes

@en

P2093

Alfonso J Carrillo-Muñoz

http://www.w3.org/2001/XMLSchema#string

Belkys Fernández-Torres

http://www.w3.org/2001/XMLSchema#string

Isabel Inza

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activity of posaconazole against clinical isolates of dermatophytes

Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards.

Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds

Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method

Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.

Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates.

Comparison of three methods of determining MICs for filamentous fungi using different end point criteria and incubation periods

Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century.

Pharmacokinetics of antifungal agents in onychomycoses.

Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients.

P304

3999-4003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.40.11.3999-4003.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

Alexandre Esteban

M Lourdes Abarca

F. Javier Cabañes

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12409365

http://www.w3.org/2001/XMLSchema#string

P921

P932

139645

http://www.w3.org/2001/XMLSchema#string